Transport of aspalathin, a Rooibos tea flavonoid, across the skin and intestinal epithelium

被引:19
作者
Huang, Miao [2 ]
du Plessis, Jeanetta [3 ]
du Preez, Jan [3 ]
Hamman, Josias [1 ]
Viljoen, Alvaro [1 ]
机构
[1] Tshwane Univ Technol, Dept Pharmaceut Sci, ZA-0001 Pretoria, South Africa
[2] Univ Witwatersrand, Dept Pharm & Pharmacol, ZA-2193 Johannesburg, South Africa
[3] NW Univ Potchefstroom Campus, Unit Drug Res & Dev, ZA-2520 Potchefstroom, South Africa
关键词
skin permeation; Caco-2; monolayers; intestinal transport; aspalathin; Rooibos tea;
D O I
10.1002/ptr.2422
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Since Rooibos tea contains high levels of flavonoid antioxidants with potential health benefits when taken orally or applied topically, the quantity of the antioxidants crossing the physiological barriers is of scientific, clinical and commercial importance. This study investigated the in vitro transport of aspalathin, a unique flavonoid constituent of Rooibos tea, across intestinal epithelial cells and the human skin. The transport studies were conducted for both pure aspalathin solutions and extracts from unfermented (or green) Rooibos (Aspalathus linearis) aerial plant material across human abdominal skin in vertical Franz diffusion cells and Caco-2 cell monolayers in Transwell 6-well plates. The results obtained from the percutaneous permeation studies demonstrated that only 0.01% of the initial aspalathin dose from both the test solution and extract permeated through the skin, which was in accordance with the prediction from its log P value of -0.347. A portion of 0.07% of the initial aspalathin dose penetrated the different layers of the skin for the green Rooibos extract solution and 0.08% for the pure aspalathin solution. The transport of aspalathin across Caco-2 cell monolayers was concentration dependent and reached almost 100% (P-app = 20.93 x 10(-6) ends) of the initial dose in the highest concentration tested for the extract, while it was only 79.03% (P-app = 15.34 x 10(-6) cm/s) of the initial dose for the highest concentration of the aspalathin solution. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:699 / 704
页数:6
相关论文
共 19 条
[1]   Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[2]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[3]   Percutaneous penetration of diethanolamine through human skin in vitro: Application from cosmetic vehicles [J].
Brain, KR ;
Walters, KA ;
Green, DM ;
Brain, S ;
Loretz, LJ ;
Sharma, RK ;
Dressler, WE .
FOOD AND CHEMICAL TOXICOLOGY, 2005, 43 (05) :681-690
[4]   Intestinal responses to xenobiotics [J].
Carrière, V ;
Chambaz, J ;
Rousset, M .
TOXICOLOGY IN VITRO, 2001, 15 (4-5) :373-378
[5]   Lipid vesicles and other colloids as drug carriers on the skin [J].
Cevc, G .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (05) :675-711
[6]   Rapid integrity assessment of rat and human epidermal membranes for in vitro dermal regulatory testing: correlation of electrical resistance with tritiated water permeability [J].
Fasano, WJ ;
Manning, LA ;
Green, JW .
TOXICOLOGY IN VITRO, 2002, 16 (06) :731-740
[7]   Skin permeation: The years of enlightenment [J].
Hadgraft, J ;
Lane, ME .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 305 (1-2) :2-12
[8]   Skin deep [J].
Hadgraft, J .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) :291-299
[9]   Oral delivery of peptide drugs -: Barriers and developments [J].
Hamman, JH ;
Enslin, GM ;
Kotzé, AF .
BIODRUGS, 2005, 19 (03) :165-177
[10]   EFFECTS OF FREEZING ON HUMAN-SKIN PERMEABILITY [J].
HARRISON, SM ;
BARRY, BW ;
DUGARD, PH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1984, 36 (04) :261-262